RichardEugeneFryeMD

Child Neurology • Phoenix, AZ

Neurodevelopmental Disabilities

Professor, Child Health, University of Arizona COM

Join to view full profile

Dr. Frye is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Frye's full profile

Already have an account?

Office
1919 E Thomas Rd
Phoenix, AZ 85016
Phone+1 602-933-0970

Fax+1 602-933-4253

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 2000 - 2003
University of Miami/Jackson Health SystemResidency, Pediatrics, 1998 - 2000
Georgetown University School of MedicineClass of 1998

Certifications & Licensure

AZ State Medical License 2017 - 2027
FL State Medical License 2022 - 2027
CA State Medical License 2023 - 2025
KY State Medical License 2018 - 2019
AR State Medical License 2011 - 2018
TX State Medical License 2007 - 2017
MA State Medical License 2003 - 2005
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Clinical Trials

Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders Start of enrollment: 2010 Jul 01
Completed
Not Applicable
A Folinic Acid Intervention for Autism Spectrum Disorders Start of enrollment: 2012 May 01
Terminated
Phase 2
Mitochondrial Dysfunction in Phelan-McDermid Syndrome Start of enrollment: 2012 May 01
Completed
Mitochondrial Dysfunction in Autism Spectrum Disorder Start of enrollment: 2012 Oct 16
Active, not recruiting
Etiology and Early Diagnosis of Neurodevelopmental Disorders Start of enrollment: 2012 May 01
Active, not recruiting
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Start of enrollment: 2014 May 01
Terminated
Phase 2
An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder Start of enrollment: 2014 Oct 31
Withdrawn
Phase 2
Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder Start of enrollment: 2020 Feb 01
Active, not recruiting
Phase 2
High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD Start of enrollment: 2019 May 21
Completed
Not Applicable
Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium Start of enrollment: 2020 Sep 22
Recruiting
Phase 2
Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism Start of enrollment: 2020 Oct 08
Recruiting
Phase 2
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders Start of enrollment: 2024 Jul 01
Not yet recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Deciduous tooth biomarkers reveal atypical fetal inflammatory regulation in autism spectrum disorder.
Dani Dumitriu, Elena Baldwin, Roozie J J Coenen, Luke A Hammond, Darcy S Peterka
Iscience. 2023-03-17
26 citations
Modern Biomarkers for Autism Spectrum Disorder: Future Directions.
Amanda R Jensen, Alison L Lane, Brianna A Werner, Sallie E McLees, Tessa S Fletcher
Molecular Diagnosis & Therapy. 2022-09-01
4 citations
Blood RNA Sequencing Indicates Upregulatedandand DownregulatedandExpression in Children with Autism Spectrum Disorder.
Irena Voinsky, Yazeed Zoabi, Noam Shomron, Moria Harel, Hanoch Cassuto
International Journal of Molecular Sciences. 2022-08-30

Press Mentions

Stealth’s Phase III Elamipretide in Mitochondrial Myopathy Has Experts Wary While FDA Approval DebatedJune 17th, 2019
Phoenix Children’s Earns $1 Million in Grants for Autism ResearchJanuary 12th, 2019
Neurologist Andrew Zimmerman Fired by DOJ for Change of OpinionJanuary 9th, 2019
Join now to see all

Grant Support

Developmental Phonological Dyslexia: Neural MechanismsNational Institute Of Neurological Disorders And Stroke2006–2009
Developmental Phonological Dyslexia: Neural MechanismsNational Institute Of Neurological Disorders And Stroke2005